EXE Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
EXE is not a clear buy right now for a beginner long-term investor with $50,000-$100,000 available. The stock has supportive analyst targets and strong revenue growth, but the technical setup is only neutral, options sentiment is bearish, hedge funds are selling, and recent earnings showed profitability at zero despite top-line growth. Because the price is sitting near resistance and there is no strong proprietary buy signal today, I would not call this a good immediate buy.
Pre-market price is 97.26, slightly down 0.16%, with the broader market pre-market up 0.34%, so EXE is lagging slightly. The MACD histogram is positive at 0.427 but contracting, which suggests momentum is still positive but fading. RSI_6 at 41.3 is neutral-to-weak, not oversold enough to signal a compelling entry. Moving averages are converging, indicating a sideways-to-cautious trend rather than a strong uptrend. Price is below the pivot at 98.853 and still under R1 at 101.968, so it has not reclaimed key near-term resistance. The short-term pattern data also points to weak near-term performance, with a -2.39% next-week expectation.
["Revenue in 2026/Q1 rose 41.03% YoY to 4.527B, showing strong top-line growth.", "Gross margin expanded to 63.64%, a strong improvement year over year.", "Several analysts remain bullish, including UBS and Truist with Buy ratings and price targets around 134-135.", "Morgan Stanley raised its price target to 141 and maintained an Overweight view."]
["William Blair downgraded the stock to Market Perform, citing slower execution and that catalysts may take quarters to play out.", "KeyBanc downgraded the stock to Sector Weight, citing management-change confusion and murky messaging.", "Hedge funds are selling, with selling increasing 103.24% over the last quarter.", "Insiders are neutral with no significant buying support.", "Q1 net income and EPS dropped to 0, indicating earnings power has not yet translated into bottom-line profits.", "Options positioning is bearish with put-call ratios above 2.0 on open interest.", "No recent news-week catalyst to drive momentum."]
In 2026/Q1, EXE delivered strong revenue growth of 41.03% YoY to 4.527B and gross margin improved to 63.64%, which is a positive operational trend. However, net income fell to 0 and EPS fell to 0, so the latest quarter did not produce earnings growth. For a long-term beginner investor, the business is improving on sales and margins, but profitability execution is still not convincing enough to justify an immediate buy based on fundamentals alone.
Analyst sentiment is mixed but still tilted positive. UBS and Truist both raised price targets to 135 and 134 respectively while keeping Buy ratings. BofA kept a Buy rating but lowered its target to 120. Morgan Stanley remains constructive with a 141 target and Overweight rating. On the bearish side, William Blair downgraded to Market Perform and KeyBanc downgraded to Sector Weight. Overall, Wall Street is still broadly positive, but confidence has weakened as some firms question execution and the timing of catalysts.
